Hepatitis C is a liver infection caused by the Hepatitis C virus (HCV). Hepatitis C is a blood-borne virus. Today, most people become infected with the Hepatitis C virus by sharing needles or other equipment to inject drugs. Sexual transmission and mother-to-child transmission are documented but uncommon except in instances of HIV co-infection. For some people, hepatitis C is a short-term illness but for 75%ï¿½85% of people who become infected with Hepatitis C, it becomes a long-term, chronic infection. Chronic Hepatitis C is a serious disease than can result in long-term health problems, even death. The majority of infected persons might not be aware of their infection because they are not clinically ill. There is no vaccine for Hepatitis C. The best way to prevent Hepatitis C is by avoiding behaviors that can spread the disease, especially injecting drugs.
Patient Assistance Programs
The Virginia Department of Health provides a treatment assistance program for eligible Hepatitis C and HIV co-infected AIDS Drug Assistance Program (ADAP) clients. The program provides Harvoni, Sovaldi, Viekira Pak and if needed, ribavirin, and payments for associated medical care and labs for uninsured clients or those whose insurance does not cover those medications.
Gilead’s Support Path™ program provides financial assistance to those who meet the income, family size, and insurance requirements. This program can help pay for medicine to treat Hepatitis C, including Harvoni® (ledipasvir/sofosbuvir) or Sovaldi® (sofosbuvir). To apply for Gilead’s Patient Assistance Program complete the